Target intelligence / Profile preview

SIDT1 antisense RNA 1 (SIDT1-AS1)

Target
SIDT1-AS1
Molecular classification
Other (non-coding RNA/long non-coding RNA)
01

Overview

SIDT1 antisense RNA 1 (SIDT1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the SIDT1 gene. It does not encode a protein but may regulate the expression of the neighboring SIDT1 gene or other molecular targets at the transcriptional or post-transcriptional level. Long non-coding RNAs such as SIDT1-AS1 are frequently studied for their roles in regulating gene expression, involvement in disease processes like cancer, and potential as prognostic or therapeutic biomarkers. To date, there is no evidence that SIDT1-AS1 itself constitutes a canonical therapeutic target such as a receptor, enzyme, transporter, or similar molecule[5]. Key distinctions: - **SIDT1-AS1** is not a protein, receptor, or conventional drug target; it is a non-coding RNA gene[5]. - **SIDT1** (not SIDT1-AS1) encodes a membrane protein involved in RNA and possibly cholesterol transport[6][1][3][4]. No evidence suggests misspelling or major ambiguity for "SIDT1-AS1," and available databases recognize this as a distinct non-coding RNA locus[5]. All major target-related lists (receptors, enzymes, etc.) do not include SIDT1-AS1 as a direct therapeutic target.

Other names
SIDT1-AS1SIDT1 Antisense RNA 1
02

Biological functions

Regulation of gene expressionPossibly involved in cancer-related processes (based on typical lncRNA functions; see description)
03

Disease associations

Cancer (long non-coding RNAs, including SIDT1-AS1, are often studied for association with cancer and as potential prognostic markers)
04

Biomarkers

Potential prognostic biomarker in cancer (based on analogs; specific evidence for SIDT1-AS1 would require further review)

Beyond the preview

Go deeper on SIDT1 antisense RNA 1 (SIDT1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SIDT1 antisense RNA 1 (SIDT1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call